Skip to main content

Biora Therapeutics, Inc.

BIORDelisted Jun 4, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001580063

Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.

Q2 2024 vs. Q1 2024

How the institutions holding Biora Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of BIOR: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders2829+1
Shares12.1M12.2M+176.4K (+1.5%)
Value$13.3M$8.07M−$5.19M (−39.1%)

New holders (7)

Institutions that held Biora Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to BIOR in Q2 2024
InstitutionSharesValue% of portfolio
Two Sigma Securities, LLC66,276$43.7K0.00%
XTX Topco Ltd16,885$11.1K0.00%
PCA Investment Advisory Services Inc.10,728$7.08K0.00%
Bank of America Corp179$1180.00%
CoreCap Advisors, LLC12$80.00%
Harbour Investments, Inc.4$30.00%
UBS Group AG2$10.00%

Sold out (6)

Institutions that held Biora Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of BIOR in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Bridgeway Capital Management, LLC26,504$29.2K
Jane Street Group, LLC17,778$19.6K
CIBC Asset Management Inc15,110$16.6K
Virtu Financial LLC11,009$12.0K
Millennium Management LLC10,890$12.0K
CWM, LLC8$0